Teladoc Health, Inc.

2 Capex and Cash Flow Cash flow from operations was $91.4 million in Second Quarter 2025, compared to $88.7 million in Second Quarter 2024, and was $107.4 million in the first six months of 2025, compared to $97.6 million in the first six months of 2024.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Capital expenditures and capitalized software development costs (together, Capex ) were $30.2 million in Second Quarter 2025, compared to $27.7 million in Second Quarter 2024, and were $61.8 million for the first six months of 2025, compared to $63.3 million for the first six months of 2024.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Revolving Credit Facility On July 17, 2025, we entered into a credit agreement providing for a five-year, $300.0 million senior secured revolving credit facility, subject to customary borrowing conditions.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

We entered into the revolving credit facility to preserve and enhance our financial and operational flexibility, and we do not currently anticipate borrowing any amounts under the facility.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Our capital allocation priorities remain unchanged and include (i) maintaining a strong balance sheet and an appropriate net leverage profile (ii) investing in the business to support our strategy through both organic and inorganic initiatives and (iii) evaluating share repurchases as a potential use of excess cash.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Free cash flow is net cash provided by operating activities less capital expenditures and capitalized software development costs.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

We continue to work with focus and urgency to advance our strategic priorities, invest in products and capabilities, and deliver solid financial performance, said Chuck Divita, Chief Executive Officer of Teladoc Health.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Our capital allocation priorities remain unchanged and include (i) maintaining a strong balance sheet and an appropriate net leverage profile (ii) investing in the business to support our strategy through both organic and inorganic initiatives and (iii) evaluating share repurchases as a potential use of excess cash.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Examples of forward-looking statements include, among others, the information under the caption Financial Outlook and statements we make regarding future financial or operating results, future numbers of members, BetterHelp paying users or clients, litigation outcomes, regulatory developments, market developments, new products and growth strategies, and the effects of any of the foregoing on our future results of operations or financial condition.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

It also includes costs related to certain business transformation initiatives focused on integrating and optimizing various operations and systems, including upgrading our customer relationship management and enterprise resource planning systems.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

We believe virtual care can be a performance multiplier to help address key challenges in an evolving healthcare landscape.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Examples of forward-looking statements include, among others, the information under the caption Financial Outlook and statements we make regarding future financial or operating results, future numbers of members, BetterHelp paying users or clients, litigation outcomes, regulatory developments, market developments, new products and growth strategies, and the effects of any of the foregoing on our future results of operations or financial condition.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

This is due to the uncertainty as to timing, and the potential variability, of the individual reconciling items such as impairments, stock-based compensation and the related tax impact, provision for income taxes, acquisition, integration, and transformation costs, and restructuring costs, the effect of which may be significant.

SEC original ↗Teladoc Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 29, 2025

Legal Proceedings 40 Item 1A.

SEC original ↗Teladoc Health, Inc. — 10-Q Quarterly report10-QJul 30, 2026

The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company s business environment; therefore, actual results could differ from these estimates.

SEC original ↗Teladoc Health, Inc. — 10-Q Quarterly report10-QJul 30, 2026